UnitedHealth Group increases premiums by 20-30% and raises 2025 earnings guidance despite Medicare pressures and DOJ scrutiny, signaling efforts to stabilize margins and adapt to regulatory challenges in the U.S. insurance market.
CMS proposes expanded 2027 Medicare Advantage benefits to include FDA-approved hemp products as supplemental coverage for chronically ill enrollees, following federal and state hemp regulations.
Explore the 2026 Medicare updates, including premium increases, plan market exits, IRMAA impacts, and strategies for effective retirement healthcare planning.
Explore Medicare Advantage employer-group market trends for 2025 with insights on enrollment growth and carrier/state membership from Mark Farrah Associates analysis of CMS data.
Former CMS Administrator Thomas Scully discusses Medicare Advantage expansion, risk adjustment challenges, healthcare quality improvements, and the impact of bipartisan politics on U.S. healthcare policy.
CMS issues proposed 2027 rules updating Medicare Advantage and Part D programs, implementing Inflation Reduction Act changes, revising star ratings, marketing oversight, and program integrity requirements.
Analyze the 2026 trends in Medicare Advantage plans focusing on supplemental benefits like dental, vision, fitness, and transportation, with insights on eligibility shifts and cost management.
Major U.S. payer-provider contracts with Blue Cross Blue Shield and UnitedHealthcare remain unresolved heading into late 2025, with potential coverage impacts for Medicare, Medicaid, and commercial plans.
Aetna and Providence Health & Services resume in-network status for Oregon commercial plan members, enhancing provider access amid rising healthcare costs and evolving insurance agreements.
Explore detailed enrollment trends for the employer-group Medicare Advantage market, which comprises 16.2% of total Medicare Advantage members as of late 2025. Insights by Mark Farrah Associates based on CMS data.
